Search Within

Population Sciences Research Program

  1. "Kenneth Offit"
  2. "Gerstner Sloan Kettering Graduate School of Biomedical Sciences"
  3. "Survivorship Research"
  4. "Vignesh Ravichandran"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
Groups
  1. Alumni (GSK) (11)
  2. Clinical Genetics Service (11)
  3. Department of Medicine (11)
  4. GSK Faculty (11)
  5. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Kenneth Offit (11)
  2. Semanti Mukherjee (11)
  3. Vignesh Ravichandran (11)
  4. Vijai Joseph (11)
  5. Zsofia Stadler (10)
  6. Mark Robson (9)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Cancer Research (2)
  3. Cancer Epidemiology Biomarkers and Prevention (1)
  4. Cancer Research (1)
  5. JAMA - Journal of the American Medical Association (1)
  6. JCO Precision Oncology (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (4)
  3. American Medical Association (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations
    Journal Article

    Liu, Y. L.; Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Tkachuk, K.; Kemel, Y.; Maio, A.; Belhadj, S.; Carlo, M. I.; Latham, A.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cascading after peridiagnostic cancer genetic testing: An alternative to population-based screening
    Journal Article

    Offit, K.; Tkachuk, K. A.; Stadler, Z. K.; Walsh, M. F.; Diaz-Zabala, H.; Levin, J. D.; Steinsnyder, Z.; Ravichandran, V.; Sharaf, R. N.; Frey, M. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC)
    Meeting Abstract

    Ku, G. Y.; Mukherjee, S.; Okoro, C.; Sharma, M.; Ravichandran, V.; Offit, K.; Joseph, V.; Janjigian, Y. Y.; Stadler, Z. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save